Floatz logo

Gamma-delta (??) T cells

Myeloid

Guangzhou Bio-gene Technology Co., LtdCell therapyEarly Phase 1Active
C
38/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
23/ 100
Competitive Position
95/ 100

Competitive context

29 Active assets in the Myeloid cohort.

Asset / SponsorPhaseRating
Mitoxantrone
First Affiliated Hospital of Zhejiang University
Phase 3BBB
Cytosin-Arabinosid
First Affiliated Hospital of Zhejiang University
Phase 3BBB
Cladribine
University of Washington
Phase 2BBB
Cyclophosphamide
Prelude Therapeutics
Phase 3BB
Idarubicine
Northwestern University
Phase 3BB

View all 49 →

Same molecule, other indications

Gamma-delta (??) T cells is also rated in:

acute diseaseDormant
C
Indicative ·
38 / 100
View asset →
hepatocellular carcinomaDormant
C
Indicative ·
35 / 100
View asset →
acute myeloid leukemiaDormant
C
Indicative ·
34 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →